126 related articles for article (PubMed ID: 35786023)
41. [The study of salivary pepsin content and laryngopharyngeal reflux scale in 91 asymptomatic volunteers].
Chen MX; Hou CJ; Chen T; Li YP; Zeng YL
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Mar; 32(6):415-419. PubMed ID: 29737735
[TBL] [Abstract][Full Text] [Related]
42. Laryngopharyngeal Reflux Disease and Gastroesophageal Reflux Disease Can Mutually Influence.
Wang X; Zhang J; Wang J; Liu Z; Zhang C; Zhao J; Zou S; Ma X; Li J
J Voice; 2022 Nov; ():. PubMed ID: 36347736
[TBL] [Abstract][Full Text] [Related]
43. Investigation of the potential relationship between gastroesophageal reflux disease and laryngopharyngeal reflux disease in symptomatology - a prospective study based on a multidisciplinary outpatient.
Wang X; Liu Z; Zhang J; Zhang C; Zhao J; Liu L; Zou S; Ma X; Li J
Scand J Gastroenterol; 2023 Jun; 58(6):589-595. PubMed ID: 36537256
[TBL] [Abstract][Full Text] [Related]
44. Clinical significance of laryngopharyngeal reflux in patients with chronic obstructive pulmonary disease.
Jung YH; Lee DY; Kim DW; Park SS; Heo EY; Chung HS; Kim DK
Int J Chron Obstruct Pulmon Dis; 2015; 10():1343-51. PubMed ID: 26203240
[TBL] [Abstract][Full Text] [Related]
45. The impact of laryngopharyngeal reflux disease on 95 hospitalized patients with COVID-19 in Wuhan, China: A retrospective study.
Jiang G; Cai Y; Yi X; Li Y; Lin Y; Li Q; Xu J; Ke M; Xue K
J Med Virol; 2020 Oct; 92(10):2124-2129. PubMed ID: 32396239
[TBL] [Abstract][Full Text] [Related]
46. Low Antioxidant Enzyme Levels and Oxidative Stress in Laryngopharyngeal Reflux (LPR) Patients.
Bulut F; Tetiker AT; Çelikkol A; Yılmaz A; Ballica B
J Voice; 2023 Nov; 37(6):924-931. PubMed ID: 34253427
[TBL] [Abstract][Full Text] [Related]
47. Role of Proton Pump Inhibitors in Laryngopharyngeal Reflux: Clinical Evaluation in a North Indian Population.
Bhargava A; Faiz SM; Srivastava MR; Shakeel M; Singh NJ
Indian J Otolaryngol Head Neck Surg; 2019 Sep; 71(3):371-377. PubMed ID: 31559206
[TBL] [Abstract][Full Text] [Related]
48. LPR: how different diagnostic tools shape the outcomes of treatment.
Wan Y; Yan Y; Ma F; Wang L; Lu P; Maytag A; Jiang JJ
J Voice; 2014 May; 28(3):362-8. PubMed ID: 24491501
[TBL] [Abstract][Full Text] [Related]
49. PepsinA as a Marker of Laryngopharyngeal Reflux Detected in Chronic Rhinosinusitis Patients.
Ren JJ; Zhao Y; Wang J; Ren X; Xu Y; Tang W; He Z
Otolaryngol Head Neck Surg; 2017 May; 156(5):893-900. PubMed ID: 28457223
[TBL] [Abstract][Full Text] [Related]
50. Multitime point pepsin testing can double the rate of the diagnosis of laryngopharyngeal reflux.
Zhang J; Li J; Zhang Y; Nie Q; Zhang R; Wang X; Jiang X; Wu Y; Wu R; Bi X; Cui X; Song H; Ran T; Li L
Laryngoscope Investig Otolaryngol; 2021 Dec; 6(6):1389-1394. PubMed ID: 34938879
[TBL] [Abstract][Full Text] [Related]
51. [The application progress on diagnostic scales of laryngopharyngeal reflux disease].
Han Y; Zhang S; Huangfu H; Liu C; Yan C
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Apr; 37(4):313-317. PubMed ID: 36987966
[No Abstract] [Full Text] [Related]
52. Prevalence of Laryngopharyngeal Reflux Disease in Indian Population.
Mishra P; Agrawal D; Chauhan K; Kaushik M
Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):1877-1881. PubMed ID: 36452745
[TBL] [Abstract][Full Text] [Related]
53. [The influence of age on the score of reflux symptom index scale and reflux finding score scale in the diagnosis of pharyngeal and laryngeal reflux].
Qi Z; Zhang Y; Su R; Niu R; Liu C
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Feb; 34(2):170-172. PubMed ID: 32086926
[No Abstract] [Full Text] [Related]
54. Effect of laryngopharyngeal reflux on the improvement of chronic rhinosinusitis without polyposis after primary endoscopic sinus surgery.
Verim A; Şeneldir L; Naiboğlu B; Tepe Karaca Ç; Kadıoğlu D; Zer Toros S
Kulak Burun Bogaz Ihtis Derg; 2016; 26(2):65-72. PubMed ID: 26890708
[TBL] [Abstract][Full Text] [Related]
55. The Role of Empirical Treatment with Proton Pump Inhibitor as a Diagnostic Tool in Laryngopharyngeal Reflux.
Chugh R
Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):1744-1751. PubMed ID: 36452527
[TBL] [Abstract][Full Text] [Related]
56. Usefulness of matrix metalloproteinase-7 in saliva as a diagnostic biomarker for laryngopharyngeal reflux disease.
Im NR; Kim B; Jung KY; Baek SK
Sci Rep; 2021 Aug; 11(1):17071. PubMed ID: 34426628
[TBL] [Abstract][Full Text] [Related]
57. The Impact of Laryngopharyngeal Reflux on Occurrence and Clinical Course of Recurrent Respiratory Papillomatosis.
Gluvajić D; Šereg-Bahar M; Jerin A; Janša R; Hočevar-Boltežar I
Laryngoscope; 2022 Mar; 132(3):619-625. PubMed ID: 34338331
[TBL] [Abstract][Full Text] [Related]
58. Different cutoffs of the reflux finding score for diagnosing laryngopharyngeal reflux disease should be used for different genders.
Gao CK; Li YF; Wang L; Han XY; Wu T; Zeng FF; Li XP
Acta Otolaryngol; 2018 Sep; 138(9):848-854. PubMed ID: 29852801
[TBL] [Abstract][Full Text] [Related]
59. Pepsin and oropharyngeal pH monitoring to diagnose patients with laryngopharyngeal reflux.
Weitzendorfer M; Antoniou SA; Schredl P; Witzel K; Weitzendorfer IC; Majerus A; Emmanuel K; Koch OO
Laryngoscope; 2020 Jul; 130(7):1780-1786. PubMed ID: 31603541
[TBL] [Abstract][Full Text] [Related]
60. [Correlation analysis between Dx-pH monitoring and proton pump inhibitor test in the diagnosis of laryngopharyngeal reflux disease].
Chen ZL; Wu HW; Mei XW; Yin WH; Xu SY; Liu SQ; Chen YC; Wang G; Zhang CJ; Ding XL; Wu JN
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Jan; 55(1):34-39. PubMed ID: 31954386
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
